Tel.: +49 89 315 700-0

2019-nCoV antigen rapid test2022-04-01T09:37:59+02:00

2019-nCoV antigen rapid test

The ready-to-use and certified BIOMED 2019-nCoV Antigen Rapid Test is a lateral flow immunoassay based on latex immunochromatography technology. It uses the double antibody sandwich method for the qualitative detection of coronavirus SARS-CoV-2 antigen (nucleocapsid protein specific) in human nasopharyngeal and oropharyngeal swab specimens. All known variants including delta, omicron, lambda etc. are reliably detected.

The test result must, of course, be analyzed in conjunction with the clinical presentation, other diagnostic information and epidemiological information to determine the patient’s current infection status. Use only by appropriately trained healthcare professionals.


Advantages of the rapid test:
  • BfArM listed under AT036/22

  • Tests all known variants incl. Delta, Omikron, Lambda etc.

  • Rapid detection and containment of disease outbreaks

  • Simple and safe handling in a few simple steps

  • Ready-to-use sample preparation kits

  • Result visible after approx. 15 minutes

  • Shelf life 24 months

  • Storage temperature in original packaging: Between +2 °C and +30 °C

  • Implementation only by trained personnel

Performance data *
2019-nCoV Antigen rapid test93,8 %99,7 %
  • The performance data of the 2019-nCoV rapid antigen test were determined in comparison to another commercially available rapid test.

Request for product

SARS-CoV-2 and COVID-19

SARS-CoV-2 (severe acute respiratory syndrome coronavirus type 2) is a new beta coronavirus that was identified in early 2020 as the causative agent of COVID-19. Beta coronaviruses also include SARS-CoV, MERS-CoV (Middle East respiratory syndrome coronavirus), and HKU1 and OC43 human coronaviruses (HCoV) circulating as “cold viruses.”

Coronaviruses are widely distributed among mammals and birds. They cause primarily mild colds in humans, but can sometimes cause severe pneumonia and be fatal.

The main route of transmission for SARS-CoV-2 is respiratory ingestion of virus-containing particles produced by breathing, coughing, talking, singing, and sneezing. Women and men are affected by SARS-CoV-2 infection at about the same rate. However, men are more likely to become severely ill and die twice as often as women, according to one review.

2019-nCoV antigen rapid test


Find out more about our POC-Diagnostics.



Go to Top